We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+7.03%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$4.5B
AUM Growth
+$857M
Cap. Flow
+$670M
Cap. Flow %
14.88%
Top 10 Hldgs %
17.64%
Holding
512
New
198
Increased
109
Reduced
79
Closed
118

Sector Composition

Rank Sector Weight
1 Healthcare 13.99%
2 Industrials 12.65%
3 Financials 10.63%
4 Consumer Discretionary 9.16%
5 Energy 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PMT
176
PennyMac Mortgage Investment
PMT
$817M
$8.08M 0.18%
368,080
+87,093
+31% +$1.94M
MR
177
DELISTED
Montage Resources Corporation Common Stock
MR
$8.07M 0.18%
+21,421
New +$8.1M
PF
178
DELISTED
Pinnacle Foods, Inc.
PF
$8.01M 0.18%
243,432
-1,087,386
-82% -$34.3M
GPT
179
DELISTED
Gramercy Property Trust
GPT
$7.76M 0.17%
+427,573
New +$7.11M
BG icon
180
Bunge Global
BG
$20.9B
$7.72M 0.17%
102,004
+27,099
+36% +$2.1M
CE icon
181
Celanese
CE
$4.86B
$7.71M 0.17%
+120,000
New +$7.28M
STNG icon
182
Scorpio Tankers
STNG
$3.84B
$7.64M 0.17%
+75,140
New +$6.86M
AREX
183
DELISTED
Approach Resources Inc.
AREX
$7.58M 0.17%
+333,453
New +$6.77M
XEC
184
DELISTED
CIMAREX ENERGY CO
XEC
$7.52M 0.17%
52,448
+1,276
+2% +$162K
MWV
185
DELISTED
MEADWESTVACO CORP
MWV
$7.51M 0.17%
169,769
+113,576
+202% +$4.61M
KBH icon
186
CALL
KB Home
KBH
$3.5B
$7.47M 0.17%
+400,000
New +$6.7M
AVDL
187
DELISTED
Avadel Pharmaceuticals
AVDL
$7.35M 0.16%
490,032
+12,396
+3% +$150K
TSN icon
188
Tyson Foods
TSN
$20.7B
$7.32M 0.16%
194,851
-62,169
-24% -$2.49M
CST
189
DELISTED
CST Brands, Inc.
CST
$7.31M 0.16%
+212,012
New +$6.89M
TMX
190
DELISTED
Terminix Global Holdings, Inc.
TMX
$7.29M 0.16%
+597,200
New +$7.32M
ACN icon
191
PUT
Accenture
ACN
$104B
$7.28M 0.16%
+90,000
New +$7.23M
HRTG icon
192
Heritage Insurance Holdings
HRTG
$1.05B
$7.27M 0.16%
+477,757
New +$6.61M
IDIX
193
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
$7.23M 0.16%
+300,000
New +$3.13M
ESNT icon
194
Essent Group
ESNT
$6.03B
$6.95M 0.15%
346,124
-13,528
-4% -$275K
INXN
195
DELISTED
Interxion Holding N.V.
INXN
$6.93M 0.15%
253,228
-27,448
-10% -$715K
ATI icon
196
ATI
ATI
$30.9B
$6.75M 0.15%
149,614
+82,183
+122% +$3.36M
CLR
197
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$6.63M 0.15%
83,874
-15,174
-15% -$1.05M
AMAP
198
DELISTED
AUTONAVI HLDGS LTD SPON ADR (CYM)
AMAP
$6.58M 0.15%
+314,910
New +$6.53M
CL icon
199
Colgate-Palmolive
CL
$73.9B
$6.58M 0.15%
96,520
-132,326
-58% -$8.87M
APOL
200
DELISTED
Apollo Education Group Inc Class A
APOL
$6.43M 0.14%
+205,924
New +$5.93M

Similar funds

Alyeska Investment Group's Q2 2014 Portfolio in Review

As of Q2 2014, Alyeska Investment Group held 512 positions worth $4.5B, up 24% from $3.64B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Alyeska Investment Group deployed $670M of net new capital in Q2 2014, opening 198 new positions and adding to 109 existing holdings. Its largest new stake was Amsurg Corp: 1,600,000 shares worth $72.9M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Pinnacle Foods, Inc., an estimated $34.3M trimmed.

  • Alyeska Investment Group's largest Q2 2014 buy was Amsurg Corp: 1,600,000 shares worth $72.9M.
  • Alyeska Investment Group added most to Capital One in Q2 2014, an estimated $18.5M increase.
  • Alyeska Investment Group's biggest Q2 2014 reduction was Pinnacle Foods, Inc., cutting an estimated $34.3M.
  • Alyeska Investment Group fully exited Pfizer in Q2 2014, selling an estimated $32.3M.
  • Alyeska Investment Group's ten largest holdings make up 18% of its $4.5B portfolio in Q2 2014.
  • Alyeska Investment Group opened 198 new positions and closed 118 in Q2 2014.
  • Alyeska Investment Group's portfolio value rose 24% quarter-over-quarter to $4.5B.

Based on Alyeska Investment Group's 13F filing for Q2 2014, filed 14 Aug 2014.